Committee for Medicinal Products for Human Use (CHMP)

“The Committee for Medicinal Products for Human Use (CHMP) is the European Medicines Agency’s (EMA) committee responsible for human medicines. The CHMP plays a vital role in the authorisation of medicines in the European Union (EU). In the centralised procedure, the CHMP is responsible for:

*conducting the initial assessment of EU-wide marketing authorisation applications;

  • assessing modifications or extensions (‘variations’) to an existing marketing authorisation;
  • considering the recommendations of the Agency’s Pharmacovigilance Risk Assessment Committee on the safety of medicines on the market and when necessary, recommending to the European Commission changes to a medicine’s marketing authorisation, or its suspension or withdrawal from the market.”

Source: Committee for Medicinal Products for Human Use (CHMP)


Take advantage of the knowledge and best practices gained from more than 20 years of research, innovation and development for the health and life sciences sectors.


The Life Sciences glossary with terminology, acronyms, for regulatory, quality, compliance, clinical trials, and pharmacovigilance software.

Found 370 Results
Page 1 of 2



Page 1 of 2